Media 16 Dec 2024 Podcast | Frazis Capital Podcast Orthocell CEO & MD, Paul Anderson, recently joined Micahel Frazis on the Frazis Capital Podcast. Orthocell
Company News 12 Dec 2024 Orthocell Achieves Major Milestone with First Sales of Remplirâ„¢ in Singapore Orthocell has today announced the achievement of first sales of Remplirâ„¢ in Singapore, marking another significant milestone in its global… Orthocell
Media 03 Dec 2024 The Australian Financial Review | Perth’s billionaires pile into medtech Orthocell Orthocell has been featured in The Australian Financial Review in an article by Health Editor Michael Smith titled “Perth’s billionaires… Orthocell
Company News 02 Dec 2024 Orthocell successfully completes US FDA 510(k) regulatory study for Remplirâ„¢ Orthocell has today reached another significant milestone with the successful completion of its Remplirâ„¢ 510(k) nerve repair regulatory study, validating… Orthocell
Media 02 Dec 2024 The Australian Business Review | Orthocell leaps closer to FDA approval after pivotal nerve-repair product study success Orthocell has been featured in The Australian Business Review, following today’s announcement that the US FDA 510(k) regulatory study of… Orthocell
Company News 27 Nov 2024 Orthocell Appoints Exclusive Distributor to Commence Sales of Remplirâ„¢ in Singapore Orthocell has announced that it has appointed Device Technologies Asia as the exclusive distributor of market leading peripheral nerve repair… Orthocell
Video 14 Nov 2024 Stockhead Long Shortz | No nerves as company enters US market Orthocell Chairman John Van Der Wielen spoke with Stockhead to discuss the Company's strategic positioning ahead of its US market… Orthocell
Video 14 Nov 2024 Meet The Board | Independent Director, Dr. Ravi Thadhani The fourth episode of Orthocell's 'Meet the Board' video series is now live - featuring Independent Director, Dr. Ravi Thadhani. Orthocell
Company News 11 Nov 2024 Appointment of Key US Executives to Lead Remplirâ„¢ Launch Orthocell has appointed two experienced US-based executives to drive the market launch and sales of Remplirâ„¢ following the expected US… Orthocell
Audio 01 Nov 2024 Equity Mates Podcast Orthocell has been named as a biotech stock to watch on a recent episode the Equity Mates Investing Podcast. Orthocell
